Hypoalbuminemia predicts the outcome of COVID‐19 independent of age and co‐morbidity

• Published in: Journal of medical virology Vol. 92; no. 10; pp. 2152 - 2158
• Main Authors: Huang, Jiaofeng, Cheng, Aiguo, Kumar, Rahul, Fang, Yingying, Chen, Gongping, Zhu, Yueyong, Lin, Su
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.10.2020; John Wiley and Sons Inc
• Subjects: Adult; Age Factors; Aged; Alanine; Alanine transaminase; Albumin; Aspartate aminotransferase; China; Comorbidity; Coronaviruses; COVID-19; COVID-19 - diagnosis; COVID-19 - physiopathology; Electronic Health Records; Female; Hospitalization - statistics & numerical data; Humans; hypoalbuminemia; Hypoalbuminemia - complications; Leukocytes; Liver Diseases - blood; Liver Diseases - complications; Lymphocytes; Lymphopenia; Male; Middle Aged; Morbidity; mortality; Multivariate Analysis; Pandemics; prediction; Retrospective Studies; risk factor; Risk Factors; Serum albumin; Viral diseases; Virology; China; COVID-19; mortality; prediction; risk factor; hypoalbuminemia

The coronavirus disease 2019 (COVID‐19) has evolved into a pandemic rapidly. Most of the literature show that the elevated liver enzymes in COVID‐19 are of little clinical significance. Lower albumin level is seen in severe COVID‐19 and is not parallel to the changes in alanine aminotransferase and...